Related Experiment Videos

Critical illness neuromuscular disease: clinical, electrophysiological, and prognostic aspects

B Tabarki1, A Coffiniéres, P Van Den Bergh

  • 1Service de neuropédiatrie et service de neurologie, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Avenue Hippocrate 10, 1200 Brussels, Belgium. bmlaiki@excite.fr

Insights

Critical illness neuromuscular disease is poorly understood in children. This study found critical illness neuropathy and myopathy cause paralysis in critically ill children, suggesting restricted corticosteroid and muscle relaxant use.

Area of Science:

  • Pediatric critical care medicine
  • Neuromuscular disorders
  • Intensive care unit (ICU) acquired weakness

Background:

  • Critical illness neuromuscular disease (CINMD) is a recognized entity in adults.
  • CINMD in pediatric populations is not well-characterized.
  • Understanding pediatric CINMD is crucial for appropriate patient management.

Observation:

  • A retrospective study was conducted at a children's university hospital.
  • Five critically ill pediatric patients with generalized paralysis were identified.
  • Patients experienced prolonged respiratory failure.

Findings:

  • The causes of paralysis included critical illness neuropathy (two patients), acute myopathy (two patients), and mixed neuromyopathy (one patient).
  • The study identified specific neuromuscular pathologies in critically ill children.
  • Electrophysiological and prognostic features were assessed.

Implications:

  • Neuromuscular disease should be suspected in critically ill children presenting with muscle weakness.
  • Corticosteroids and muscle relaxants may precipitate CINMD in children.
  • Restricting or minimizing the use of these agents is recommended to prevent or mitigate pediatric CINMD.
Abstract

Related Concept Videos